WebApr 18, 2024 · Opus Biotech Communications [email protected] 425-306-8716 On April 18, 2024 / Nanoscope Press Release, Home Page Nanoscope In The News Modern Retina: Nanoscope Therapeutics announces WHO selection of ‘sonpiretigene isteparvovec’ as international nonproprietary name for MCO-010 Read more→ WebApr 4, 2024 · The company's pipeline includes therapies for RP, Stargardt, other Inherited Retinal Degenerations, and Geographic Atrophies. For more information visit: …
Opus Biotech Communications LinkedIn
WebSep 21, 2024 · NanOlogy, NanoDoce, and NanoPac are trademarks of NanOlogy LLC. Contacts Dan Eramian Opus Biotech Communications [email protected] +425-306-8716 Charles Craig Opus Biotech... WebBiotechnology. Headquarters Regions Washington DC Metro Area, East Coast, Southern US. Founded Date 2004. Operating Status Active. Also Known As Lentigen. Company Type For … dickinson state women\u0027s basketball
Nanoscope
WebOPUS The OPUS team is located to serve clients in key biotech and life sciences hubs across the US. Seattle: Daniel Eramian 425-306-8716 [email protected] San … OPUS Biotech Communications Blog. 5 Keys to a Deck that Delivers. February 4, … Opus Biotech Communications Adds New Clients Web and social media expert, … OPUS Biotech Communications Blog; ... OPUS has extensive experience working … OPUS Biotech has an extensive network of contacts built on decades of experience … WebApr 26, 2024 · Opus Biotech Communications, a life sciences public affairs and investor relations consultancy based in Seattle with branches in Atlanta, Newport Beach and San … WebOpus Biotech Communications Daniel Eramian 425-306-8716 [email protected] Charles Craig 404-245-0591 [email protected]. Home About Technology Development News & Publications Contact. citrix receiver won\\u0027t open